Browse by all authors Browse By Author Name - Scanlon,+M.

Browse Results (13 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Garcia, E., Scanlon, M. and Naranjo, D. (1999) A Marine Snail Neurotoxin Shares with Scorpion Toxins a Convergent Mechanism of Blockade on the Pore of Voltage-gated K Channels. Journal of General Physiology, 114 1: 141-157. doi:10.1085/jgp.114.1.141 81   24 Cited 21 times in Scopus21 0
Reid, R. C., Abbenante, G., March, D. R., Scanlon, M. and Fairlie, D. P. (1997) A novel strategy for the design of potent peptidomimetic inhibitors of proteolytic enzymes: Application to HIV-1 protease.. Abstracts of Papers of The American Chemical Society, 214 177-MEDI. 75   0
Fairlie, D. P., Tyndall, J. D. A., Reid, R. C., Wong, A. K., Abbenante, G., Scanlon, M. J., March, D. R., Bergman, D. A., Chai, C. L. L. and Burkett, B. A. (2000) Conformational selection of inhibitors and substrates by proteolytic enzymes: Implications for drug design and polypeptide processing. Journal of Medicinal Chemistry, 43 7: 1271-1281. doi:10.1021/jm990315t 103   104 Cited 106 times in Scopus106 0
Sokolenko, N., Abbenante, G., Scanlon, M. J., Jones, A., Gahan, L. R., Hanson, G. R. and Fairlie, D. P. (1999) Cyclooligomerization of Thiazole-Containing Tetrapeptides. Symmetrical Macrocycles with up to 76 Amino Acids. Journal of the American Chemical Society, 121 11: 2603-2604. doi:10.1021/ja983354n 68   40 Cited 42 times in Scopus42 0
Meutermans, W., Bourne, G. T., Golding, S., Horton, D., Campitelli, M. R., Craik, D. J., Scanlon, M. J. and Smythe, M. L. (2003) Difficult macrocyclizations: New strategies for synthesizing highly strained cyclic tetrapeptides. Organic Letters, 5 15: 2711-2714. doi:10.1021/ol034907o 90   44 Cited 44 times in Scopus44 0
Heras, B, Shouldice, S. R., Totsika, M, Scanlon, M. J., Schembri, M. A. and Martin, J. L. (2009) DSB proteins and bacterial pathogenicity. Nature Reviews Microbiology, 7 3: 215-225. doi:10.1038/nrmicro2087 71 4 106 Cited 100 times in Scopus100 3
Hayman, W. A., Toth, I., Flinn, N., Scanlon, M. and Good, M. F. (2002) Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunology And Cell Biology, 80 2: 178-187. doi:10.1046/j.1440-1711.2002.01067.x 59   28 Cited 29 times in Scopus29 0
Duprez, W., Lakshmanane, P., Kurth, F., Bachu, P., Halili, M., Cooper, M., Scanlon, M., Fairlie, D. P. and Martin, J. L. (2013). Inhibiting Virulence in E. coli: Screening of Peptidomimetics Ttargeting the DsbA Disulfide Bond Formation Machinery. In: Biopolymers. 23rd American Peptide Symposium, Waikoloa Hi, (302-302). Jun 22-27, 2013. 13   0
Craik, D. J. and Scanlon, M. J. (2000). Marine toxins as a starting point for drugs. In Luis M Botana (Ed.), Seafood and Freshwater Toxins Pharmacology, Physiology and Dection (pp. 715-740) New York: Marcel Dekker Inc. 69  
Craik, D. J. and Scanlon, M. J. (2000). Pharmaceutical Applications of NMR. In Webb and GA (Ed.), Annual Reports on NMR Spectroscopy (pp. 115-174) USA: Academic Press. 76  
Rosengren, K. J., Daly, N. L., Scanlon, M. J. and Craik, D. J. (2001) Solution structure of BSTI: A new trypsin inhibitor from skin secretions of Bombina bombina. Biochemistry, 40 15: 4601-4609. doi:10.1021/bi002623v 72   13 Cited 12 times in Scopus12 0
Vivian, J. P., Scoullar, J, Rimmer, K, Bushell, S. R., Beddoe, T, Wilce, M. C. J., Byres, E, Boyle, T. P., Doak, B, Simpson, J. S., Graham, B, Heras, B, Kahler, C. M., Rossjohn, J and Scanlon, M. J. (2009) Structure and Function of the Oxidoreductase DsbA1 from Neisseria meningitidis. Journal of Molecular Biology, 394 5: 931-943. doi:10.1016/j.jmb.2009.09.065 411   15 Cited 14 times in Scopus14 0
Schirra, H. J., Scanlon, M. J., Lee, M. C. S., Anderson, M. A. and Craik, D. J. (2001) The solution structure of C1-T1, a two-domain proteinase inhibitor derived from a circular precursor protein from Nicotiana alata. Journal of Molecular Biology, 306 1: 69-79. doi:10.1006/jmbi.2000.4318 65   15 Cited 16 times in Scopus16 0